CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nattopharma ASA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nattopharma ASA
Lilleakerveien 2B
Phone: +47 40009008p:+47 40009008 OSLO, 0283  Norway Fax: +47 67200251f:+47 67200251

This company was Merged or Acquired on 5/25/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Nattopharma ASA is a Norway-based biotechnology company, which sells and develops products containing natural vitamin K2. The Company markets its products under its own trademark MenaQ7, principally in Europe and North America. MenaQ7 is provided either as powder or as an oil solution, and is used in stand-alone form, in complex dietary products and as additives to functional products. Nattopharma ASA offers contract manufacturing of dietary products, biochemical tests, marketing and sales support services. It provides its products primarily to the healthcare, supplement and functional food markets. The Company has an alliance with VitaK BV, at the Cardiovascular Research Institute (CARIM) at the University of Maastricht in the Netherlands.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202012/31/2020Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Frode M.Bohan 49 8/28/2012 2/13/2012
Chief Executive Officer KjetilRamsoy 3/9/2020 1/1/2016
Chief Financial Officer RobertSchrama 3/9/2020 3/9/2020
11 additional Officers and Directors records available in full report.

Business Names
Business Name
0ICZ
MenaQ7 Crystals
MGP Diagnostics AS
NATTO
NATTOO
Nattopharma ASA

General Information
Number of Employees: 18 (As of 12/31/2020)
Outstanding Shares: 19,836,290 (As of 12/31/2020)
Shareholders: 820
Stock Exchange: OSL
Fax Number: +47 67200251


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 1, 2024